Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11077108
Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition
granted -
US 11072594
Trioxolane agents
granted -
US 11072600
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted -
US 11072592
Small molecules that enable cartilage rejuvenation
granted -
US 11072629
Reprogramming of cellular adhesion
granted -
US 11066647
Pluripotent human adipose adult stem cells: isolation, characterization and clinical implications
granted -
US 11065347
Methods for the treatment of Danon disease and other disorders of autophagy
granted -
US 11065280
Hepatocytes with high regenerative capacity for liver repair
granted -
US 11066481
Antibodies to coagulation factor XIa and uses thereof
granted -
US 11065264
Metal-olsalazine coordination polymers for medical applications
granted -
US 11060087
Synthetic promoters for high throughput screening and gene modulation
granted -
US 11061094
Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)
granted -
US 11058645
Inhibition of respiratory complex III by ligands that interact with a regulatory switch
granted -
US 11059817
Potent antiviral pyrazolopyridine compounds
granted -
US 11053310
Antibodies for the treatment of cancers
granted -
US 11052044
In situ lipid synthesis for protein reconstitution
granted -
US 11052089
Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype
granted -
US 11046941
Methods of generating nucleic acid fragments
granted -
US 11045493
Synthetic melanin nanoparticles and uses thereof
granted -
US 11045555
Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles
granted -
US 11046730
Antimicrobial compositions
granted -
US 11040091
Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function
granted -
US 11041023
Chimeric antigen receptors for phagocytosis
granted -
US 11034933
Methods for selectively expanding and enriching cells transduced with chimeric antigen receptors and treating HIV infection
granted